Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How

Published on 24 Nov 2023 on Zacks via Yahoo Finance

Kiniksa Pharmaceuticals, Ltd. KNSA has been performing well in the last six months, thanks to positive regulatory and pipeline updates.

Shares of the company have gained 14.7% year-to-date against the industry’s decline of 14.8%.

Zacks Investment Research

Read the rest of the article

Start tracking your investments with Statfolio

It's been a good week for Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) shareholders, because the c...

Simply Wall St. via Yahoo Finance 26 Apr 2024

Kiniksa Pharmaceuticals (NASDAQ:KNSA) has reported a significant increase in its financial...

Investing.com 24 Apr 2024

Kiniksa Pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.25 per share versus the...

Zacks via Yahoo Finance 23 Apr 2024

Kiniksa Pharmaceuticals (NASDAQ:KNSA) has reported substantial growth in the fourth quarter and...

Investing.com 1 Mar 2024

Kiniksa Pharmaceuticals, Ltd. (KNSA) closed the last trading session at $21.14, gaining 16.1% ove...

Zacks via Yahoo Finance 1 Mar 2024

Kiniksa Pharmaceuticals (NASDAQ:KNSA) has reported substantial growth in the fourth quarter and...

Investing.com 1 Mar 2024

Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA), a biopharmaceutical company focused on the discovery, ...

GuruFocus.com via Yahoo Finance 29 Feb 2024

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript February 28, 2024 Ki...

Insider Monkey via Yahoo Finance 29 Feb 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Ultrapar Participações S...

Zacks via Yahoo Finance 29 Feb 2024

Michael Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA), has sold 9,...

GuruFocus.com via Yahoo Finance 23 Dec 2023